Yahoo Finance • last month
We recently compiled a list of the 8 Most Profitable Penny Stocks To Invest In.In this article, we are going to take a look at where OraSure Technologies Inc. (NASDAQ:OSUR) stands against the other profitable penny stocks. Potential in Sm... Full story
Yahoo Finance • last year
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today annou... Full story
Yahoo Finance • last year
Participants Carrie Eglinton Manner; President, CEO & Director; OraSure Technologies, Inc. Jason Plagman Kenneth J. McGrath; CFO; OraSure Technologies, Inc. Andrew Harris Cooper; Research Analyst; Raymond James & Associates, Inc., Rese... Full story
Yahoo Finance • last year
Q3 GAAP EPS of $0.15; Q3 Non-GAAP EPS of $0.27 Grew cash balance to $224.9 million as of September 30, 2023 BETHLEHEM, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home... Full story
Yahoo Finance • last year
BETHLEHEM, Pa., Oct. 23, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2023 financial results and certain business developments for 5:00 pm ET... Full story
Yahoo Finance • last year
BETHLEHEM, Pa., June 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and at-home diagnostic testing, as well as non-invasive self-sampling technologies and microbiome-focused bioco... Full story
Yahoo Finance • 2 years ago
Most readers would already be aware that OraSure Technologies' (NASDAQ:OSUR) stock increased significantly by 48% over the past three months. However, we decided to pay attention to the company's fundamentals which don't appear to give a c... Full story
Yahoo Finance • 2 years ago
InteliSwab® test revenue of $118.3 million in Q1, up 33% sequentially; Company delivers cost savings and begins to taper InteliSwab® test production and expenses Gross margins increase 200 basis points sequentially despite mix/pricing hea... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 first quarter financial results and certain business developments for 5:00 p.m. E... Full story
Yahoo Finance • 2 years ago
InteliSwab® revenue of $88.9 million in Q4, up 12% sequentially; wins two new federal government contracts extending the tail on InteliSwab® revenue Signs a deal with Quest Diagnostics Genomic Sequencing Services for saliva collection kit... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 fourth quarter financial results and certain business developments for 5:00 pm E... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., Dec. 01, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, will ring the closing bell for the Nasdaq Stock Market this afternoon in honor of World AIDS Day. Worl... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Ken... Full story
Yahoo Finance • 2 years ago
InteliSwab® revenue of $79.6 million in Q3, up 85% sequentially; Company continues to expand test production capacity Company wins new contracts for COVID-19 testing along with retail wins including availability on Amazon.com Q3 GAAP EPS... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 third quarter financial results and certain business developments for 5:00 pm ET... Full story
Yahoo Finance • 2 years ago
InteliSwab® revenue of $43.1 million in Q2, up 95% sequentiallywith significant scaling in production InteliSwab® gross margins improve sequentially by over 2,000 basis points GAAP gross margin of 34.4%, a decrease of 200 basis points se... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 second quarter financial results and certain business developments for 5:00 p.m.... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its OMNIgene®•GUT DNA and... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., June 08, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that on June 4, 2022, OraSure’s... Full story
Yahoo Finance • 2 years ago
BETHLEHEM, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 Ra... Full story